[Effect of therapy on iron metabolism in patients with progressive chronic polyarthritis].
D000740:Anemia / Q000150:complications; D000747:Anemia, Hypochromic / Q000150:complications; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000150:complications / Q000188:drug therapy*; D001799:Blood Sedimentation; D001854:Bone Marrow Cells; D002738:Chloroquine / Q000627:therapeutic use*; D003864:Depression, Chemical; D004906:Erythrocyte Count; D006386:Hemagglutination Tests; D006454:Hemoglobins / Q000032:analysis; D006485:Hemosiderin / Q000032:analysis*; D006801:Humans; D007501:Iron / Q000097:blood*; D007592:Joint Diseases / Q000097:blood / Q000188:drug therapy; D010653:Phenylbutazone / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D013122:Spinal Diseases / Q000097:blood / Q000188:drug therapy; D013885:Thiosulfates / Q000627:therapeutic use*; D014168:Transferrin / Q000032:analysis; D014228:Triaziquone / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D006454:Hemoglobins; D013885:Thiosulfates; D014168:Transferrin; D002738:Chloroquine; D006485:Hemosiderin; D007501:Iron; D014228:Triaziquone; D010653:Phenylbutazone; D011241:Prednisone
Therapieeinflüsse auf den Eisenstoffwechsel bei Patienten mit progressiv chronischer Polyarthritis.